Patents/Assignees

SHANGHAI ZHIMENG BIOPHARMA, Inc.

5 patents in portfolio

US12492170utility2025
Tetrahydro-1h-benzazepine Compound as Potassium Channel Modulator, Preparation Method and Use Thereof
0 cites
US12486265utility2025
2-aminopyrimidine Compounds and Pharmaceutical Compositions and Uses Thereof
0 cites
US12473276utility2025
Compound Having Neuroprotective Effect, Preparation Method Therefor and Use Thereof
0 cites
US12319656utility2025
Compound as Potassium Channel Regulator and Preparation and Use Thereof
0 cites
US12157726utility2024
P-phenylenediamine Derivative as Potassium Channel Regulator and Preparation Method and Medical Application Thereof
0 cites